Leong Jiayu, Hong Yu-Tong, Wu Yu-Fu, Ko Eunkyung, Dvoretskiy Svyatoslav, Teo Jye Yng, Kim Byoung Soo, Kim Kyeongsoo, Jeon Hojeong, Boppart Marni, Yang Yi Yan, Kong Hyunjoon
Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.
Institute of Bioengineering and Nanotechnology, 31 Biopolis Way, Singapore 138669, Singapore.
ACS Nano. 2020 May 26;14(5):5298-5313. doi: 10.1021/acsnano.9b04926. Epub 2020 Apr 13.
Stem cell transplantation has been a promising treatment for peripheral arterial diseases in the past decade. Stem cells act as living bioreactors of paracrine factors that orchestrate tissue regeneration. Prestimulated adipose-derived stem cells (ADSCs) have been proposed as potential candidates but have been met with challenges in activating their secretory activities for clinical use. Here, we propose that tethering the ADSC surface with nanoparticles releasing tumor necrosis factor α (TNFα), named nanostimulator, would stimulate cellular secretory activity . We examined this hypothesis by complexing octadecylamine-grafted hyaluronic acid onto a liposomal carrier of TNFα. Hyaluronic acid increased the liposomal stability and association to CD44 on ADSC surface. ADSCs tethered with these TNFα carriers exhibited up-regulated secretion of proangiogenic vascular endothelial growth factor and immunomodulatory prosteoglandin E2 (PGE) while decreasing secretion of antiangiogenic pigment epithelium-derived factors. Accordingly, ADSCs tethered with nanostimulators promoted vascularization in a 3D microvascular chip and enhanced recovery of perfusion, walking, and muscle mass in a murine ischemic hindlimb compared to untreated ADSCs. We propose that this surface tethering strategy for stimulation of stem cells would replace the costly and cumbersome preconditioning process and expedite clinical use of stem cells for improved treatments of various injuries and diseases.
在过去十年中,干细胞移植一直是治疗外周动脉疾病的一种有前景的方法。干细胞作为旁分泌因子的活体生物反应器,可协调组织再生。预刺激的脂肪来源干细胞(ADSCs)已被提出作为潜在候选者,但在激活其分泌活性以用于临床方面面临挑战。在此,我们提出用释放肿瘤坏死因子α(TNFα)的纳米颗粒(称为纳米刺激器)连接ADSC表面,将刺激细胞分泌活性。我们通过将十八烷基胺接枝的透明质酸与TNFα的脂质体载体复合来检验这一假设。透明质酸增加了脂质体稳定性以及与ADSC表面CD44的结合。与这些TNFα载体连接的ADSCs表现出促血管生成的血管内皮生长因子和免疫调节性前列腺素E2(PGE)的分泌上调,同时抗血管生成的色素上皮衍生因子的分泌减少。因此,与纳米刺激器连接的ADSCs在三维微血管芯片中促进了血管生成,并且与未处理的ADSCs相比,增强了小鼠缺血后肢的灌注恢复、行走能力和肌肉质量。我们提出这种用于刺激干细胞的表面连接策略将取代昂贵且繁琐的预处理过程,并加速干细胞在临床上的应用,以改善对各种损伤和疾病的治疗。